Impaired P50 suppression in fear extinction in obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 2, 2010, Pages 317-322

  Nanbu, Makoto ^a   Kurayama, Taichi ^a   Nakazawa, Ken ^a   Matsuzawa, Daisuke ^a   Komiya, Zen ^a   Haraguchi, Tadashi ^a   Ogura, Hirohisa ^a   Hashimoto, Tasuku ^a   Yoshida, Susumu ^a   Iyo, Masaomi ^a   Shimizu, Eiji ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Auditory evoked potential; Classical fear conditioning; Fear extinction; Obsessive compulsive disorder; P50 suppression; Sensory gating

Indexed keywords

CLOMIPRAMINE; FLUVOXAMINE; PAROXETINE; SERTRALINE; TRAZODONE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONDITIONING; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEAR; FEMALE; FUNCTIONAL ELECTRICAL STIMULATION; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PROTEIN EXPRESSION; REINFORCEMENT; VISUAL STIMULATION;

ADULT; BIOPHYSICS; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SENSORY GATING; YOUNG ADULT;

EID: 77649269981     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.12.005     Document Type: Article

References (47)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982, 17:639-654.
2. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993, 150:1856-1861.
3. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998, 24:189-202.
4. Adler L.E., Olincy A., Cawthra E.M., McRae K.A., Harris J.G., Nagamoto H.T., et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 2004, 161:1822-1828.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC 1994.
6. Arciniegas D.B., Topkoff J.L., Rojas D.C., Sheeder J., Teale P., Young D.A., et al. Reduced hippocampal volume in association with p50 nonsuppression following traumatic brain injury. J Neuropsychiatry Clin Neurosci 2001, 13:213-221.
7. Beck A., Ward C., Mendelson M., Mock J., Frbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-591.
8. Bouton M.E., Westbrookb R.F., Corcoranc K.A., Maren S. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 2006, 60:352-360.
9. Braff D.L., Light G.A., Swerdlow N.R. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 2007, 61:1204-1207.
10. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 2005, 29:399-419.
11. Cheng Dominic T., Knight David C., Smith Christine N., Helmstetter Fred J. Human amygdala activity during the expression of fear responses. Behav Neurosci 2006, 120:1187-1195.
12. Choi J.S., Kim H.S., Yoo S.Y., Ha T.H., Chang J.H., Kim Y.Y., et al. Morphometric alterations of anterior superior temporal cortex in obsessive-compulsive disorder. Depress Anxiety 2006, 23:290-296.
13. de Wilde O.M., Bour L.J., Dingemans P.M., Koelman J.H., Linszen D.H. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophr Res 2007, 97:137-151.
14. Dubrvina N.I., Zinov'ev D.R. Contribution of GABA receptors to extinction of memory traces in normal conditions and in a depression-like state. Neurosci Behav Physiol 2008, 38:775-779.
15. Ghisolfi E.S., Heldt E., Zanardo A.P., Strimitzer I.M., Prokopiuk A.S., Becker J., et al. P50 sensory gating in panic disorder. J Psychiatr Res 2006, 40:535-540.
16. Ghisolfi E.S., Schuch A., Strimitzer I.M., Luersen G., Martins F.F., Ramos F.L., et al. Caffeine modulates P50 auditory sensory gating in healthy subjects. Eur Neuropsychopharmacol 2006, 16:204-210.
17. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989, 46:1006-1016.
18. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C., et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 2000, 54:142-147.
19. Grunwald T., Boutros N.N., Pezer N., von Oertzen J., Fernandez G., Schaller C., et al. Neuronal substrates of sensory gating within the human brain. Biol Psychiatry 2003, 53:511-519.
20. Hammer T.B., Oranje B., Glenthoj B.Y. The effects of imipramine on P50suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol 2007, 1-9.
21. Hashimoto T., Shimizu E., Koike K., Orita Y., Suzuki T., Kanahara N., et al. Deficient in auditory P50 inhibition in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:288-296.
22. Herrmann M.J., Jacob C., Unterecker S., Fallgatter A.J. Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping. Psychiatry Res 2003, 120:265-271.
23. Jerger K., Biggins C., Fein G. P50 suppression is not affected by attentional manipulations. Biol Psychiatry 1992, 31:365-377.
24. Koike K., Hashimoto K., Takai N., Shimizu E., Komatsu N., Watanabe H., et al. Tropisetron improves deficits in auditory P50 suppression in schizophrenia. Schizophr Res 2005, 76:67-72.
25. Kurayama T., Nakazawa K., Matsuzawa D., Yoshida S., Nanbu M., Suto C., et al. Alterations of auditory P50 suppression in human fear conditioning and extinction. Biol Psychiatry 2009, 65:495-502.
26. Kwon J.S., Shin Y.W., Kim C.W., Kim Y.I., Youn T., Han M.H., et al. Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 2003, 74:962-964.
27. LaBar K.S., Gatenby J.C., Gore J.C., LeDoux J.E., Phelps E.A. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998, 20:937-945.
28. Liechti M.E., Geyer M.A., Hell D., Vollenweider F.X. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 2001, 24:240-252.
29. Lundberg S., Carlssonb A., Norfeldta P., Carlsson M.L. Nicotine treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1195-1199.
30. Metzger L.J., Carson M.A., Paulus L.A., Lasko N.B., Paige S.R., Pitman R.K., et al. Event-related potentials to auditory stimuli in female Vietnam nurse veterans with posttraumatic stress disorder. Psychophysiology 2002, 39:49-63.
31. Michael T., Blechert J., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in panic disorder: enhanced resistance to extinction. J Abnorm Psychol 2007, 116:612-617.
32. Myers K.M., Davis M. Mechanisms of fear extinction. Mol Psychiatry 2007, 12:120-150.
33. Neylan T.C., Fletcher D.J., Lenoci M., McCallin K., Weiss D.S., Schoenfeld F.B., et al. Sensory gating in chronic posttraumatic stress disorder: reduced auditory P50 suppression in combat veterans. Biol Psychiatry 1999, 46:1656-1664.
34. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., Pitman R.K. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J Abnorm Psychol 2000, 109:290-298.
35. Pasquini M., Garavini A., Biondi M. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:157-159.
36. Patterson J.V., Hetrick W.P., Boutros N.N., Jin Y., Sandman C., Stern H., et al. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res 2008, 158:226-247.
37. Phillips M.A., Langley R.W., Bradshaw C.M., Szabadi E. The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 2000, 14:40-45.
38. Rauch S.L., Wedig M.M., Wright C.I., Martis B., McMullin K.G., Shin L.M., et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007, 61:330-336.
39. Sanders Matthew J., Wiltgen Brian J., Michael S., Fanselow M.S. The place of the hippocampus in fear conditioning. Eur J Pharmacol 2003, 463:217-223.
40. Sotres-Bayon F., Cain C.K., LeDoux J.E. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 2006, 60:329-336.
41. Stein Dan J. Obsessive-compulsive disorder. Lancet 2002, 360:397-405.
42. Thornton A.R., Harmer M., Lavoie B.A. Selective attention increases the temporal precision of the auditory N100 event-related potential. Hear Res 2007, 230:73-79.
43. Tregellas J.R., Davalos D.B., Rojas D.C., Waldo M.C., Gibson L., Wylie K., et al. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 2007, 92:262-272.
44. van Luijtelaar Gilles. The effect of diazepam on sensory gating in healthy volunteers. Neurosci Lett 2003, 341:65-68.
45. van Luijtelaar Gilles.The effects of diazepam on sensory gating in healthy volunteers. Neurosci Lett 2003, 341:65-68.
46. White P.M., Yee C.M. Effects of attentional and stressor manipulations on the P50 gating response. Psychophysiology 1997, 34:703-711.
47. Zouridakis G., Boutros N.N. Stimulus parameter effects on the P50 evoked response. Biol Psychiatry 1992, 32:39-41.